Expertise in
6
conditions

Dr. Stacey Rifkin-Zenenberg

Pediatric Hematology Oncology
Hackensack University Medical Center
30 Prospect Avenue, Joseph M. Sanzari Childrenas Hospital, 
Hackensack, NJ 
Accepting New Patients
Referral may be required
Before you request
Expertise in
6
conditions
Hackensack University Medical Center
30 Prospect Avenue, Joseph M. Sanzari Childrenas Hospital, 
Hackensack, NJ 

Overview

Stacey Rifkin-Zenenberg is a Pediatric Hematologist Oncology provider practicing medicine in Hackensack, New Jersey.

Dr. Rifkin-Zenenberg is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Acute Megakaryoblastic Leukemia, Anemia, Hemolytic Anemia, and Bone Marrow Aspiration.

Dr. Rifkin-Zenenberg is board certified in Pediatric Hematology-Oncology and American Board Of Pediatrics . She is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 4 clinical trials. Dr. Rifkin-Zenenberg is currently accepting new patients.

Specialties

Pediatric Hematology Oncology

Licenses

Pediatrics in NJ

Board Certifications

Pediatric Hematology-Oncology
American Board Of Pediatrics

Fellowships

Long Island Jewish Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

Hackensack University Medical Center
30 Prospect Avenue, Joseph M. Sanzari Childrenas Hospital, Hackensack, NJ 7601.

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Enrollment Status: Completed
Publish Date: April 30, 2026
Intervention Type: Drug, Radiation, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Vincristine
Study Phase: Phase 3
A Phase 2,Multicenter,Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab,With or Without Hydroxyurea/Hydroxycarbamide,in Sequential,Descending Age Groups of Pediatric Sickle Cell Disease Patients With Vaso-Occlusive Crisis
A Phase 2,Multicenter,Open-Label Study to Assess Appropriate Dosing and to Evaluate Safety of Crizanlizumab,With or Without Hydroxyurea/Hydroxycarbamide,in Sequential,Descending Age Groups of Pediatric Sickle Cell Disease Patients With Vaso-Occlusive Crisis
Enrollment Status: Completed
Publish Date: October 16, 2025
Intervention Type: Drug
Study Drug: Crizanlizumab
Study Phase: Phase 2
A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Other
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens Including Rare Pediatric Tumors
Enrollment Status: Completed
Publish Date: July 19, 2018
Intervention Type: Other
View 3 Less Clinical Trials

8 Total Publications

Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease.
Base Editing of HBG1 and HBG2 Promoters for Sickle Cell Disease.
Journal: The New England journal of medicine
Published: April 03, 2026
Similar Doctors
Expertise in
9
conditions
Dr. Banu Aygun
Pediatric Hematology Oncology
Expertise in
9
conditions
Dr. Banu Aygun
Pediatric Hematology Oncology
Referral may be required
Before you request

Northwell Health Pediatric Hematology/Oncology & Stem Cell Transplant

269-01 76th Avenue, Suite 255, 
New Hyde Park, NY 
 (19.7 miles away)
718-470-3460
Languages Spoken:
English, Turkish
See accepted insurances
Accepting New Patients

Banu Aygun is a Pediatric Hematologist Oncology provider practicing medicine in New Hyde Park, New York. Dr. Aygun is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Splenectomy. Dr. Aygun is currently accepting new patients.

Expertise in
7
conditions
Dr. Jeffrey M. Lipton
Pediatric Hematology Oncology
Expertise in
7
conditions
Dr. Jeffrey M. Lipton
Pediatric Hematology Oncology
Referral may be required
Before you request

Northwell Health Pediatric Hematology/Oncology & Stem Cell Transplant

269-01 76th Avenue, Suite 255, 
New Hyde Park, NY 
 (19.7 miles away)
718-470-3460
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jeffrey Lipton is a Pediatric Hematologist Oncology provider practicing medicine in New Hyde Park, New York. Dr. Lipton is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Aase Syndrome, Pure Red Cell Aplasia, Transient Erythroblastopenia of Childhood, Aplastic Anemia, and Bone Marrow Transplant. Dr. Lipton is board certified in American Board Of Pediatrics. Dr. Lipton is currently accepting new patients.

Expertise in
6
conditions
Dr. James B. Bussel
Pediatric Hematology Oncology
Expertise in
6
conditions
Dr. James B. Bussel
Pediatric Hematology Oncology
Referral may be required
525 E 68th St # P-695, 
New York, NY 
 (9.6 miles away)
212-746-3400
Languages Spoken:
English
See accepted insurances

James Bussel is a Pediatric Hematologist Oncology provider practicing medicine in New York, New York. Dr. Bussel is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP), Blood Clots, Anemia, Evans Syndrome, and Splenectomy.

Frequently Asked Questions about Dr. Stacey Rifkin-Zenenberg

How do I make an appointment with Dr. Stacey Rifkin-Zenenberg?

You can book an appointment with Dr. Stacey Rifkin-Zenenberg by calling their office at 551-996-5437. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Stacey Rifkin-Zenenberg a top-rated expert for Sickle Cell Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stacey Rifkin-Zenenberg is classified as an Distinguished expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Stacey Rifkin-Zenenberg specialize in?

While Dr. Stacey Rifkin-Zenenberg is a Pediatric Hematology Oncology, they have specific expertise in Sickle Cell Disease, Acute Megakaryoblastic Leukemia, and Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Hematology Oncology.

Does Dr. Stacey Rifkin-Zenenberg participate in research or clinical trials?

Yes. Dr. Stacey Rifkin-Zenenberg has published 8 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Dr. Stacey Rifkin-Zenenberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Stacey Rifkin-Zenenberg accept my insurance?

Dr. Stacey Rifkin-Zenenberg accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 551-996-5437 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rifkin-Zenenberg's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile